Experiments by Li Z. et al. (2021) demonstrated that hydroxycarboxylic acid receptor-2 mediated tumor development and progression by promoting gut mucosal immunity and reducing the expression of oncogenes. The gene discussed is HCAR2; the disease is neoplasm.